| Andrew Cluster | University of California | A Phase 1 Study of Modified Measles Virus (MV-NIS) for the Treatment of Children and Young Adults with Recurrent Medulloblastoma or Recurrent Atypical Teratoid Rhabdoid Tumors (ATRT) |
| Jonathan Cooper | NIH/R21 | Defining and treating peripheral nervous system dysfunction in Cln1 disease |
| Megan Cooper | NIH/P01/UCSF | STAT3 variants as a rheostat of immune tolerance |
| Patricia Dickson | NIH/R03 | Cellular phenotype of mucopolysaccharidosis II for studies of genomic variants |
| Sarah Garwood | Healthy Blue | Healthy Blue Partnership |
| Nicole Gilbert | NIH/R03 | Deciphering the source and consequences of Nur77 expression during E. coli rUTI in mice |
| Michelle Gill | SLCH Foundation | CDI Pediatric Pulmonary Disease & Asthma Center (PPD&A) |
| Robert Hayashi | NIH/U10/Public Health Institute | Work Load Intensity – NIH NCTN |
| Katie Plax | MU | ECHO – Hub Team Member |
| Katie Plax | CDC/Vivent Health | Comprehensive High-Impact HIV Prevention Programs for Community-Based Organizations |
| Robert Potter | American Urological Association Foundation | Genomic diversity driving the commensal-pathogen axis in the urogenital tract |
| Daniel Rosenbluth | CFF | WU Therapeutics Development Center |
| Joshua Rubin | NIH/T32 | Pediatric Training Program Hematology and Oncology |
| Stephen Sykes | NIH/R01 | Targeting the Unfolded Protein Response in Leukemia Biology and Chemotherapy Resistance |
| Xunjun Xiao | NIH/R01 | Pathophysiology of Chronic Pancreatitis Associated with Misfolded PNLIP Risk Variants |
